Ethanol enhances glutamate transmission by retrograde dopamine signaling in a postsynaptic neuron/synaptic bouton preparation from the ventral tegmental area.
It is well documented that somatodendritically released dopamine is important in the excitability and synaptic transmission of midbrain dopaminergic neurons. Recently we showed that in midbrain slices, acute ethanol exposure facilitates glutamatergic transmission onto dopaminergic neurons in the ventral tegmental area (VTA). The VTA is a brain region critical to the rewarding effects of abused drugs, including ethanol. We hypothesized that ethanol facilitation might result from an increase in somatodendritically released dopamine, which acts retrogradely on dopamine D(1) receptors on glutamate-releasing axons and consequently leads to an increase in glutamate release onto dopaminergic neurons. To further test this hypothesis and to examine whether ethanol facilitation can occur at the single-cell level, VTA neurons were freshly isolated from rat brains using an enzyme-free procedure. These isolated neurons retain functional synaptic terminals, including those that release glutamate. Spontaneous excitatory postsynaptic currents (sEPSCs) mediated by glutamate alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors were recorded from these freshly isolated putative dopaminergic neurons. We found that acute application of clinically relevant concentrations of ethanol (10-80 mM) significantly facilitated the frequency of sEPSCs but not their mean amplitude. Ethanol facilitation was mimicked by the D(1) agonist SKF 38393 and by the dopamine uptake blocker GBR 12935 but was blocked by the D(1) antagonist SKF 83566, and by depleting dopamine stores with reserpine, as well as by chelating postsynaptic calcium with BAPTA. Furthermore, the sodium channel blocker tetrodotoxin eliminated the facilitation of sEPSCs induced by ethanol but not by SKF 38393. These results constitute the first evidence from single isolated cells of ethanol facilitation of glutamate transmission to dopaminergic neurons in the VTA. In addition, we show that ethanol facilitation has a postsynaptic origin and a presynaptic locus. Furthermore, ethanol stimulation of a single dopaminergic neuron is capable of eliciting the release of somatodendritic dopamine, which is sufficient to influence glutamatergic transmission at individual synapses.
Deng
Chunyu
C
Department of Anesthesiology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ 07103-2714, USA.
Li
Ke-Yong
KY
Zhou
Chunyi
C
Ye
Jiang-Hong
JH
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002492:Central Nervous System Depressants / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents / Q000378:metabolism; D000431:Ethanol / Q000494:pharmacology*; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects; D018698:Glutamic Acid / Q000378:metabolism*; D066298:In Vitro Techniques; D009474:Neurons / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D017447:Receptors, Dopamine D1 / Q000819:agonists / Q000037:antagonists & inhibitors; D017470:Receptors, Glutamate / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D026941:Sodium Channel Blockers / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects*; D017557:Ventral Tegmental Area / Q000187:drug effects* / Q000502:physiology
D002492:Central Nervous System Depressants; D002614:Chelating Agents; D015259:Dopamine Agents; D017447:Receptors, Dopamine D1; D017470:Receptors, Glutamate; D026941:Sodium Channel Blockers; D000431:Ethanol; D018698:Glutamic Acid; D002118:Calcium; D004298:Dopamine
J Neurophysiol. 2007 Mar;97(3):1977-85
16956995
Neuroscience. 2006;138(1):25-35
16378694
J Neurosci. 1999 Nov 15;19(22):9780-7
10559387
Brain Res Rev. 2008 Aug;58(2):290-302
18042492
J Neurosci. 1987 Sep;7(9):2794-806
3625274
J Neurosci. 2005 Jun 29;25(26):6199-207
15987949
Brain Res. 1985 Nov 25;348(1):201-3
2998561
Proc Natl Acad Sci U S A. 1982 Jul;79(14):4456-60
6956874
J Pharmacol Exp Ther. 1999 Jul;290(1):325-33
10381795
Alcohol. 1996 Nov-Dec;13(6):569-74
8949951
J Neurochem. 2005 Jun;93(6):1469-81
15935063
Alcohol Clin Exp Res. 2008 Apr;32(4):690-8
18341645
Neuropsychopharmacology. 2009 Jan;34(2):307-18
18596684
J Pharmacol Exp Ther. 2006 Jun;317(3):1155-60
16501066
J Physiol. 1987 Apr;385:243-86
2443667
Brain Res. 1990 Jan 29;508(1):65-9
2337793
Brain Res. 2005 Oct 26;1060(1-2):126-37
16212943
J Neurosci. 2006 Mar 8;26(10):2788-97
16525058
J Neurosci. 1997 Aug 1;17(15):5738-46
9221772
J Neurosci. 2004 Oct 13;24(41):8961-74
15483115
Nature. 1981 Feb 12;289(5798):537-42
6258083
Pharmacol Ther. 2005 Jul;107(1):80-98
15963352
Science. 1989 Mar 31;243(4899):1721-4
2467382
Neurochem Int. 2006 Dec;49(8):737-45
16901588
Brain Res. 1975 Jan 17;83(3):531-7
1111820
J Neurosci. 1989 Apr;9(4):1233-41
2703874
Exp Brain Res. 1994;100(3):395-406
7813678
J Psychiatry Neurosci. 2004 Jul;29(4):296-310
15309046
J Neurosci. 1995 Jul;15(7 Pt 2):5379-88
7623160
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4904-9
18347345
Nature. 1976 Mar 18;260(5548):258-60
1256567
Neuroscience. 2008 Apr 22;153(1):240-8
18343590
Science. 2001 Sep 28;293(5539):2465-70
11577238
Brain Res. 1984 Feb 27;294(1):127-32
6697228
J Neurochem. 1990 Dec;55(6):2111-6
1977890
J Physiol. 2000 Feb 15;523 Pt 1:163-73
10673553
J Neurophysiol. 2006 Feb;95(2):619-26
16148268
J Comp Neurol. 1997 Nov 24;388(3):484-94
9368855
J Neurosci Methods. 2006 Dec 15;158(2):251-9
16842860
Neuron. 2004 Jun 24;42(6):939-46
15207238
Brain Res Brain Res Rev. 1997 Dec;25(3):312-34
9495561
J Neurosci. 2006 Sep 27;26(39):10043-50
17005867
Brain Res. 1990 Jul 30;524(1):31-41
2400930
Eur J Pharmacol. 1997 Apr 11;324(1):1-10
9137907
J Neurosci. 1997 Apr 1;17(7):2519-30
9065512
Trends Pharmacol Sci. 2003 Jan;24(1):44-7
12498731
J Neurochem. 2000 Oct;75(4):1685-93
10987851
J Physiol. 2006 Dec 15;577(Pt 3):907-24
16959856
J Neurosci. 2007 May 23;27(21):5730-43
17522317
Eur J Neurosci. 2007 Jan;25(1):106-18
17241272
Alcohol Clin Exp Res. 2007 Jul;31(7):1106-13
17577392
Biochem Pharmacol. 2008 Jan 1;75(1):218-65
17706608
J Neurochem. 1991 Mar;56(3):961-7
1993900
Adv Biochem Psychopharmacol. 1977;16:433-8
883551
J Neurosci. 1996 Jul 1;16(13):4135-45
8753875
Neurosci Lett. 2007 Oct 2;425(3):188-91
17845833
J Neurosci. 2004 Jan 7;24(1):53-62
14715937
Neurosci Biobehav Rev. 2004 Jul;28(4):415-31
15289006
Alcohol Clin Exp Res. 2008 Jun;32(6):1040-8
18422836
J Neurosci. 2004 Nov 24;24(47):10652-9
15564581
Alcohol Clin Exp Res. 2003 Oct;27(10):1573-82
14574227
Br J Pharmacol. 2002 Feb;135(3):816-22
11834630
J Neurosci. 2006 Aug 16;26(33):8549-58
16914681
Alcohol Clin Exp Res. 1999 Nov;23(11):1848-52
10591603
Alcohol Clin Exp Res. 1998 Aug;22(5):998-1040
9726269
Neurochem Res. 1995 Feb;20(2):159-69
7783840
J Neurosci. 2004 Feb 4;24(5):1050-7
14762123
Nature. 1993 Nov 25;366(6453):344-7
8247128
Neuroscience. 1996 Feb;70(4):1025-37
8848165
J Pharmacol Exp Ther. 2004 Oct;311(1):282-9
15169831